Research programme: ion channel modulators - SWITCH Biotech
Alternative Names: Psoriasis therapies research programme - SWITCH Biotech; SWT 01.103; SWT 01.1xx; SWT 01.2xx; SWT 01103Latest Information Update: 02 Jun 2005
At a glance
- Originator SWITCH Biotech (CEASED)
- Class
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 01 Mar 2005 Discontinued - Preclinical for Psoriasis in Germany (unspecified route)
- 01 Mar 2005 SWITCH Biotech has closed down
- 30 Jan 2003 Preclinical trials in Psoriasis in Germany (unspecified route)